Skip to Content

TEVA 5550 (Dexmethylphenidate Hydrochloride Extended-Release 5 mg)

Pill with imprint TEVA 5550 is Blue, Capsule-shape and has been identified as Dexmethylphenidate Hydrochloride Extended-Release 5 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Dexmethylphenidate is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dexmethylphenidate 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 5550

Dexmethylphenidate hydrochloride extended-release 5 mg TEVA 5550
Dexmethylphenidate hydrochloride extended-release 5 mg TEVA 5550
Dexmethylphenidate hydrochloride extended-release 5 mg TEVA 5550

Dexmethylphenidate Hydrochloride Extended-Release

Imprint
TEVA 5550
Strength
5 mg
Color
Blue
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5550

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.